A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
‘I’ve got Elon Musk dying’: Voice clone baffles tech billionaire
These Stocks Are Moving the Most Today: Ford, Thor, Costco, Coty, and More
Flat Earther left humiliated after trying to argue with a scientist
TikTok fined $368 million in Europe for failing to protect children
Phenom Ranked Among Inc. 5000’s Fastest-Growing Companies for Fourth Consecutive Year
China to Curb Graphite Exports. What It Means for Tesla and Other EV Stocks.
Celent Report Finds Personetics Is the Top Banking Solution for Small Business Banking in North America
Netflix Steps Up Videogame Challenge to Microsoft. The Cloud Is Its Battlefield.